查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571948

全球生物义肢市场

Bioprosthetics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 92 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生物义肢市场将达到 119 亿美元

2023年全球生物义肢市场估计为63亿美元，预计2030年将达到119亿美元，2023-2030年分析期间复合年增长率为9.5%。异种移植生物假体是本报告分析的细分市场之一，预计复合年增长率为 10.0%，到分析期结束时将达到 83 亿美元。在分析期间，同种异体移植生物假体部分的复合年增长率估计为 8.4%。

美国市场预计16亿美元，中国预计复合年增长率14.1%

到 2023 年，美国生物义肢市场预计将达到 16 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达31亿美元，2023-2030年分析期间复合年增长率为14.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.9% 和 8.5%。在欧洲，德国的复合年增长率预计约为 5.9%。

全球生物农药市场－主要趋势与驱动因素总结

生物农药如何彻底改变农业？

生物农药正成为现代农业的游戏规则改变者，为传统化学农药提供永续且环保的替代方案。这些农药源自天然或生物来源，例如微生物、植物抽取物和其他有机化合物，以更特异性、更环保的方式针对害虫。生物农药旨在有效控制害虫、疾病和杂草，同时最大限度地减少对环境的负面影响。它们因其对人类、有益昆虫和野生动物等非目标生物体的低毒性而越来越受欢迎。随着世界对永续农业的日益关注以及对有机农产品的需求不断增长，生物农药已成为害虫综合治理 (IPM) 计划的重要组成部分。这些产品不仅保护农作物，也支持生物多样性和土壤健康，使其成为农民平衡生产力与生态责任的重要工具。随着农业产业面临越来越大的减少化学农药使用的监管压力，生物农药为保护作物产量和环境提供了可行的解决方案。

最终用途如何影响生物农药的采用？

生物农药在各个农业领域的应用正在迅速扩大，其中水果、蔬菜和特种作物是需求的主要驱动力。这些作物通常对病虫害高度敏感，并从作为精密农业策略一部分的生物农药的针对性作用中受益匪浅。例如，有机和永续农民越来越多地使用生物农药、杀虫剂、杀菌剂和除草剂来防治病虫害，而不损害其有机资质。在园艺领域，生物处理产品广泛用于保护观赏植物和草坪，为公共空间、公园和高尔夫球场提供更安全的替代方案。此外，这些杀虫剂在公共卫生领域的媒介传播疾病管理方面正在取得进展，其中控制蚊子和其他携带疾病的昆虫非常重要。除田间作物外，生物农药也应用于温室栽培。由于温室栽培的受控环境，保持害虫防治和植物健康之间的平衡非常重要。生物农药在不同领域的使用日益增多，凸显了它们的多功能性和在现代农业中日益增长的重要性。

科技在生物农药的进步中扮演什么角色？

技术进步在提高生物农药的有效性和应用方面发挥着重要作用，使农民更可靠、更容易获得它们。先进发酵和配方技术的发展提高了微生物生物农药的稳定性、保质期和功效，使其在农业中广泛采用。此外，无人机和感测器技术等精密农业技术创新使得生物农药的散布更有针对性，减少浪费并确保只在需要的地方进行处理。这种精确度不仅提高了害虫防治的效率，也减少了农药使用的整体环境足迹。此外，生物技术的进步正在开发基因工程生物农药，这些农药对有益生物体更安全，但对抗性害虫更有效。这些创新加上人工智慧驱动的预测模型，可以实现更好的害虫监测和精确的农药散布时间，以最大限度地提高其有效性。此外，数位农业工具和生物农药散布的日益一体化将使农民能够采用更永续的害虫管理方法，这符合资料主导农业的全球趋势。

推动生物农药市场成长的因素有哪些？

生物农药市场的成长受到多种因素的推动，例如对永续农业方法的需求增加、对化学农药使用的严格规定以及消费者对有机食品和无农药残留食品的偏好的改变。主要驱动因素之一是人们对合成化学农药相关环境和健康风险的认识不断提高，促使消费者和政府寻求更安全的替代方案。主要农业经济体的监管机构正在加强对传统农药使用的监管，导致生物农药产品的采用增加。此外，消费者对有机和永续种植食品的需求不断增加也鼓励农民将生物农药纳入其害虫管理策略的一部分。另一个因素是害虫对化学农药的抗药性日益普遍，这使得具有新颖作用方式的生化解决方案成为更具吸引力的选择。生物技术和配方技术的创新也透过提高这些产品的功效和保质期来促进市场成长。此外，综合害虫管理 (IPM) 计划在传统农业和有机农业中的扩展正在推动对生物农药的需求，作为 IPM 强调的永续和有针对性的方法的补充。随着农业部门继续优先考虑永续性和生产力，生物农药市场预计将稳定成长。

受访企业范例（36家知名企业）

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21347

Global Bioprosthetics Market to Reach US$11.9 Billion by 2030

The global market for Bioprosthetics estimated at US$6.3 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Xenograft Bioprosthetics, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in the Allograft Bioprosthetics segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 14.1% CAGR

The Bioprosthetics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Biorational Pesticides Market – Key Trends & Drivers Summarized

How Are Biorational Pesticides Revolutionizing Agriculture?

Biorational pesticides are emerging as a game-changer in modern agriculture, offering a sustainable and environmentally friendly alternative to traditional chemical pesticides. These pesticides, derived from natural or biological origins such as microorganisms, plant extracts, or other organic compounds, target pests in a more specific and eco-friendly manner. Biorational pesticides are designed to minimize negative environmental impacts while effectively controlling pests, diseases, and weeds. They are gaining popularity due to their reduced toxicity to non-target organisms, including humans, beneficial insects, and wildlife. With the increasing global focus on sustainable agriculture and the growing demand for organic produce, biorational pesticides are becoming an integral part of Integrated Pest Management (IPM) programs. These products not only help protect crops but also support biodiversity and soil health, making them a critical tool for farmers seeking to balance productivity with ecological responsibility. As the agricultural industry faces increasing regulatory pressures to reduce chemical pesticide use, biorational pesticides offer a viable solution to safeguard both crop yields and the environment.

How Are End-Use Applications Shaping the Adoption of Biorational Pesticides?

The application of biorational pesticides is expanding rapidly across various agricultural sectors, with fruits, vegetables, and specialty crops being key drivers of demand. These crops, which are often highly sensitive to pests and diseases, benefit significantly from the targeted action of biorational pesticides, which are applied as part of precision agriculture strategies. For example, organic and sustainable farmers are increasingly adopting biorational insecticides, fungicides, and herbicides to manage pests and diseases without compromising their organic certification. In horticulture, biorational products are widely used to protect ornamentals and turf, offering a safer alternative for public spaces, parks, and golf courses. Additionally, these pesticides are gaining traction in the management of vector-borne diseases in public health, where controlling mosquitoes and other disease-carrying insects is critical. Beyond field crops, biorational pesticides are finding applications in greenhouse cultivation, where maintaining a balance between pest control and plant health is crucial due to the controlled environment. The expanding use of biorational pesticides across diverse sectors highlights their versatility and growing importance in modern agriculture.

What Role Does Technology Play in Advancing Biorational Pesticides?

Technological advancements are playing a crucial role in enhancing the effectiveness and application of biorational pesticides, making them more reliable and accessible for farmers. The development of advanced fermentation and formulation technologies has improved the stability, shelf-life, and potency of microbial-based biorational products, enabling their broader adoption in agriculture. Additionally, innovations in precision agriculture, such as drones and sensor technologies, are enabling more targeted application of biorational pesticides, reducing wastage and ensuring that the treatments are applied only where needed. This precision not only enhances pest control efficiency but also reduces the overall environmental footprint of pesticide usage. Furthermore, advancements in biotechnology have led to the creation of genetically engineered biopesticides that are more effective against resistant pests while remaining safe for beneficial organisms. These innovations, along with AI-driven predictive models, allow for better pest monitoring and more accurate timing of pesticide applications, maximizing their efficacy. The growing integration of digital farming tools with biorational pesticide application is also helping farmers adopt more sustainable pest management practices, aligning with global trends toward data-driven agriculture.

What Factors Are Driving Growth in the Biorational Pesticides Market?

The growth in the biorational pesticides market is driven by several factors, including increased demand for sustainable farming practices, stringent regulations on chemical pesticide use, and shifting consumer preferences towards organic and residue-free food. One of the key drivers is the growing awareness of the environmental and health risks associated with synthetic chemical pesticides, prompting both consumers and governments to seek safer alternatives. Regulatory bodies in major agricultural economies are tightening restrictions on the use of traditional pesticides, leading to increased adoption of biorational products. Furthermore, the rising consumer demand for organic and sustainably grown food is pushing farmers to embrace biorational pesticides as part of their pest management strategy. Another factor is the increasing prevalence of pest resistance to chemical pesticides, which has made biorational solutions, with their novel modes of action, a more attractive option. Technological innovations in biotechnology and formulation techniques are also contributing to market growth by improving the efficacy and shelf-life of these products. Additionally, the expansion of Integrated Pest Management (IPM) programs in both conventional and organic farming is driving the demand for biorational pesticides, as they complement the sustainable and targeted approach that IPM emphasizes. As the agricultural sector continues to prioritize sustainability and productivity, the market for biorational pesticides is expected to grow steadily.

Select Competitors (Total 36 Featured) -

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bioprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Propels Demand for Bioprosthetic Heart Valves
    • Technological Advancements in Tissue Engineering Drive Innovation in Next-Generation Bioprosthetics
    • Growing Preference for Minimally Invasive Surgeries Spurs Adoption of Bioprosthetic Implants
    • Increasing Use of Bioprosthetic Materials in Orthopedic Applications Expands the Addressable Market
    • Improved Biocompatibility and Longevity of Bioprosthetics Strengthens Their Adoption in Cardiovascular and Orthopedic Surgeries
    • Growing Focus on Customized Bioprosthetic Solutions for Personalized Medicine Creates New Market Opportunities
    • Rising Demand for Aesthetic and Functional Bioprosthetics in Reconstructive Surgeries Drives Market Growth
    • Advances in Xenotransplantation Technologies Expand the Development and Adoption of Bioprosthetic Devices
    • Increasing R&D in Biomaterials and Biopolymer Technologies Propels Innovation in Bioprosthetic Design
    • Favorable Reimbursement Policies in Developed Markets Drive Adoption of Bioprosthetic Implants in Healthcare Systems
    • Growing Role of 3D Printing in Manufacturing Custom Bioprosthetics Expands Opportunities for Personalized Implants
    • Increasing Incidence of Sports Injuries and Trauma Surgeries Generates Demand for Bioprosthetic Ligaments and Tendons
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Xenograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Allograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Plastic Surgery & Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Bioprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • JAPAN
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CHINA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • EUROPE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • FRANCE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • GERMANY
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • INDIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AFRICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030

IV. COMPETITION